Pre-procedure treatment of thrombocytopenia associated with chronic liver disease

This indication refers to the short-term, prophylactic elevation of low platelet counts in adult patients with chronic liver disease who are scheduled to undergo an invasive medical, surgical, or dental procedure Pre-procedure management aims to temporarily stimulate thrombopoiesis and achieve adequate hemostatic levels, thereby minimizing bleeding risks and reducing the need for donor platelet transfusions

Thrombocytopenia is a common hematologic complication in advanced hepatic dysfunction, primarily driven by decreased hepatic synthesis of thrombopoietin, increased splenic sequestration from portal hypertension, and accelerated platelet destruction

Thrombocytopenia is a common hematologic complication in advanced hepatic dysfunction, primarily driven by decreased hepatic synthesis of thrombopoietin, increased splenic sequestration from portal hypertension, and accelerated platelet destruction When counts drop below safe procedural thresholds—frequently fewer than 50,000 platelets per microliter—patients face a heightened risk of perioperative hemorrhage, which can lead to delayed or canceled interventions Pre-procedure management aims to t...

When counts drop below safe procedural thresholds—frequently fewer than 50,000 platelets per microliter—patients face a heightened risk of perioperative hemorrhage, which can lead to delayed or canceled interventions

Pre-procedure management aims to temporarily stimulate thrombopoiesis and achieve adequate hemostatic levels, thereby minimizing bleeding risks and reducing the need for donor platelet transfusions